Systemic onset juvenile idiopathic arthritis: Clinical course;Formes systemiques d'arthrite juvenile idiopathique: Aspects evolutifs

Presse Medicale

Volumn 29, Issue 9, 2000, Pages 503-509

  Prieur, A M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GOLD SALT; HLA ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

AMYLOIDOSIS; CHILD; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; PROGNOSIS; REVIEW; AGE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GROWTH DISORDER; INFANT; MACROPHAGE ACTIVATION; MALE; PRESCHOOL CHILD; RADIOGRAPHY; SYNDROME; TIME;

AGE FACTORS; AMYLOIDOSIS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; INFANT; MACROPHAGE ACTIVATION; MALE; PROGNOSIS; SYNDROME; TIME FACTORS;

EID: 0034635843     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis : Durban 1997. J Rheumatol 1998 ; 25:1991-4.
2. Houten SM, Kuis W, Duran M et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulin D and periodic fever syndrome. Nat Genet 1999; 22:175-7.
3. Drenth JP, Cuisset L, Grateau G et al. Mutations in the gene encoding mevalonate kinase cause hyper-lgD and periodoc fever syndrome. International Hyper-lgD Study Group. Nat Genet 1999 ; 22:178-81.
4. MC Dermott MF, Aksentijevich I, Galon T et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominanatly inherted autoinflammatory syndromes. Cell 1999 ; 97:133-44.
5. Tromp G, Kuivaniemi H, Raphael S et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 1996 ; 59:1097-107.
6. Cuisset L, Drenth JP, Berthelot JM et al. Genetic linkage of the Muckle-Wells syndrome to chromosome to 1q44. Am J Hum Genet 1999 ; 62:1054-9.
7. The French FMF Consortium A candidate gene for Familial Mediteranean Fever. Nature Genet 1997 ; 17:25-31.
8. Prieur AM, Griscelli C, Lampert F et al. A chronic infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity in 30 patients Scand J Rheumatol (suppl), 1987 ; 66:57-68.
9. Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphtous stomatitis. J Pediatr 1987;110:43-6.
10. Prieur AM, Griscelli C. Aspects nosologiques des frames systémiques d'arthrite juvénile à début précoce. A propos de dix sept observations. Ann Pédiatr 1983 ; 30:565-9.
11. Prieur AM, Roux-Lombard P, Dayer JM. Dynamics of fever and the cytokine network in systemic juvenil arthritis. Rev Rheum 1996 ; 63:163-70.
12. Yancey CL, Dought RA, Cohlan BA, Athreya BH. Pericarditis and cardiac tamponade in juvenile rheumatoid arthritis. Pediatrics 1981 ; 68:369-73.
13. Posnanski AK, Hernandez RJ, Guire KE et al. Etude des marqueurs d'histocompatiblité et de l'hétérogénéité de la forme systémique d'arthrite chronique juvénile. A propos de 108 patients. Rev Rhum Mal Ostéoart 1996 ; 63:11-18.
14. Miller ML, Aarons S, Jackson J et al. HLA gène frequencies in children and adults with systemic onset juvenil theumatoid arthritis. Arthritis Rheum 1985 ; 28:146-50.
15. Desaymard C, Kaplan C, Fournier C et al. Etude des marqueurs d'histocompatibité et de l'hétérogénéité de la forme systémicue d'arthrite chronique juvénile. A propos de 108 patients. Rev Rhum Mal Ostéoart 1996 ; 63:11-18.
16. Prieur AM, Stavropoulos-Glokas C, Germenis A et al. Juvenile chronic arthritis (JCA): 12th International Histocompatibility Workshop study. In: Genetic D, EDK Paris 1997 ; 398-407.
17. De Benedetti F, Martini A, Is systemic juvenile Rheumatoid Arthritis an Interleukin 6 mediated disease? J Rheumatol 1998 ; 25:203-7
18. Mangge H, Kenzia H, Gallistl S et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995 ; 38:211-20.
19. Rooney M, David J, Simons J et al. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatal 1995 ; 34:454-60.
20. De Benedetti F, Pignatti P, Massa M et al. Circulating levels of interleukin 1 ß and of interleukin-1 receptor antagonist in systemic juvenile rheumatoid arthritis. Clin Exp Rheumatol 1995 ; 13:779-84.
21. De Benedetti F, Massa M, Pignatti P et al. Serum soluble IL-6 receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994 ; 93:2114-19.
22. Tilg H, Trehu E, Atkins MB et al. Interleukin -6 (IL6) as an anti-inflammatory cytokine : induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p 55. Blood 1994 ; 83:113-18.
23. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990 ; 265:621-32.
24. D'Hont V, Humblet Y, Guillaume TH et al. Thromboponcetic effects and toxicity of Interleukm-6 in patients with ovarian cancer before and after chemotherapy. A multicentric placebo-controlled phase Ib study. Blood 1995 ; 85:2347-53.
25. Jongen-Laurenvie M, Peetres HRM, Rozemuller H et al. IL-6 induced anemia in rats : possible pathogenic implications for anemia observed in chronic inflammation, Clin Exp Immunol 1996 ; 103:328-34.
26. De Benedetti F, Alonzi T, Moretta A et al. IL-6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor I: a model for stunted growth in children with chronic inflammation. J Clin Invest 1997 ; 99:643-50.
27. De Benedetti F, Massa M, Robbioni P et al. Correlation of serum Interleukin 6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991 ; 34:1158-63.
28. Modesto C, Prieur AM. Proposition d'un index prévisionnel de sévérité articulaire au début des formes systémiques d'arthrite chronique juvénile (FS-ACJ), Rev Rhum 1996; 63. 795 (résumé 23).
29. Schneider R, Lang BA, Relly BJ et al Prognostic indicators of joint destruction in systemic onset juvenile rheumatoid arthritis. J Pediatr 1992 ; 120:200-5.
30. Deschenes G, Prieur AM, Hayem F et al. Renal amyloidosis in juvenile chronic arthritis. Evolution after chlorambucil therapy. Pediatr Nephrol 1990 ; 4:465-9.
31. David J, Vouyiouka O, Ansell BM et al. Amyloidosis in, juvenile chronic arthritis : a morbidity and mortality study, Clin Exp Rheumatol 1993 ; 11:85-90.
32. Woo P, O'brien J, Robson M, Ansel BM. A genetic mark for amyloidosis in juvenile arthritis. Lancet 1987 ; 2:767-9.
33. Hertzberger-Ten Cate R, Cats A. Toxicity of sulphasalazine in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1991 ; 9:86-8.
34. Hadchouel M, Prieur AM, Griscelli C. Acute hemormagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis : possible relationship to drugs or infection. J Pediatr 1985; 106:561-6.
35. Stephan JL, Zeller J, Hubert P et al Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993 ; 11 451-6.
36. Prieur AM, Stephan JL. Syndrome d'activation macrophagique au cours des maladies rhumatismales chez l'enfant. Rev Rhum 1994 : 61:447-51.
37. Benrett AE, Silverman ED, Miller JIII, Hintz RL. Insulin-like growth factors I and Il in children with systemic onset juvenile arthritis. J Rheumatol 1988; 15:655-8.
38. Simon D, Touati G, Prieur AM et al. Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis. Acto paediatr 1999 ; suppl 428:100-5.
39. Henderson CJ, Lovell DJ, Gregg DJ. A nutritional screening test for use in children and adolescents with juvenile rheumatoid arthritis. J Rhumatol 1992 ; 19:1276-81.
40. Prieur AM, Bremard-Oury C, Griscelli C, Mozziconacci P. Pronostic des formes systémiques d'arthrite chronicue juvénile. A propos de 100 cas. Arch Fr Pediatr 1984 ; 41:91-7.
41. Hafner R, Truckenbrodt H. Course and prognosis of systemic juvenile chronic arthritis. Retrospective study of 187 patients. Klin padiatr 1985 ; 198:401-7.
42. Stoeber E. Prognosis in juvenile chronic arthritis. Followup of 433 chronic rheumatic children. Eur J Pediatr 1981 ; 135:225-8.
43. Salliere D, Segond P, Bisson M, Massias P. Long-term follow-up study of juvenile chronic arthritis. Sem Hop 1981 ; 57:1155-60.
44. Hafner R, Truckenbrodt H. Course and prognosis of systemic juvenile chronic arthritis - retrospective study of 187 patients. Klin Padiatr 1986 ; 198:401-7.
45. Cabane J, Michon A, Ziza JM et al. Comparison of long-term evolution of adult onset and juvenile onset Still's disease, both followed for more than 10 years. Ann Rheum Dis 1990 ; 49:283-5.
46. Rossouw DJ, Burnet R, David J, Woo P, Mc Cullough CJ. The juvenile arthritic in adult life : a surgical profile. J Orth Rheumatol 1993 ; 6:11 -16.
47. Hayem F, Calede C, Hayem G, Kahn MF. Involvement of the hip in systemic-onset forms of juvenile chronic arthritis. Retrospective study of 28 cases. Rev Rheum 1994 ; 61:583-9.
48. David J, Cooper C, Hickey L, Lloyd J et al The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol 1994 ; 33:876-81.
49. Peterson LS, Mason T, Nelsor AM et al. Psychological outcomes and health status of adults who have had juvenile rheumatoid arthritis. Arthritis Rheum 1997 ; 40:2235-40.